Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice
by
Miller, Richard A
, Strong, Randy
, Schmidt, Thomas M
, Ericsson, Aaron C
, Smith, Byron J
, Harrison, David C
in
Acarbose
/ Acarbose - pharmacology
/ Acetic acid
/ Animals
/ Bacteria
/ Bacteria - classification
/ Bacteria - drug effects
/ Bacteria - isolation & purification
/ Biological Microscopy
/ Biomedical and Life Sciences
/ Case-Control Studies
/ Communities
/ Community composition
/ Composition
/ Dependence
/ Dietary restrictions
/ Digestive system
/ Esters
/ Fatty acids
/ Fatty Acids, Volatile - metabolism
/ Fecal microflora
/ Feces
/ Feces - chemistry
/ Feces - microbiology
/ Female
/ Females
/ Fermentation
/ Fermentation - drug effects
/ Future predictions
/ Gastrointestinal Microbiome - drug effects
/ Gastrointestinal tract
/ Gene expression
/ Glucosidase
/ Gut microbiome
/ Gut microbiota
/ Hazards
/ Health insurance
/ Hypoglycemic agents
/ Intestinal microflora
/ Life Sciences
/ Life span
/ Longevity
/ Longevity - drug effects
/ Male
/ Males
/ Mice
/ Microbe-host interactions and microbial pathogenicity
/ Microbial activity
/ Microbiology
/ Microbiomes
/ Microbiota
/ Microbiota (Symbiotic organisms)
/ Microorganisms
/ Muribaculaceae
/ Mycology
/ Parasitology
/ Phylogeny
/ Physiology
/ Population
/ Predictive control
/ Propionic acid
/ Proportional Hazards Models
/ Research Article
/ Retirement benefits
/ S24-7
/ Sex
/ Sexes
/ Short-chain fatty acids
/ Standard deviation
/ Starch
/ Survival analysis
/ Taxonomy
/ Virology
/ α-Glucosidase
2019
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice
by
Miller, Richard A
, Strong, Randy
, Schmidt, Thomas M
, Ericsson, Aaron C
, Smith, Byron J
, Harrison, David C
in
Acarbose
/ Acarbose - pharmacology
/ Acetic acid
/ Animals
/ Bacteria
/ Bacteria - classification
/ Bacteria - drug effects
/ Bacteria - isolation & purification
/ Biological Microscopy
/ Biomedical and Life Sciences
/ Case-Control Studies
/ Communities
/ Community composition
/ Composition
/ Dependence
/ Dietary restrictions
/ Digestive system
/ Esters
/ Fatty acids
/ Fatty Acids, Volatile - metabolism
/ Fecal microflora
/ Feces
/ Feces - chemistry
/ Feces - microbiology
/ Female
/ Females
/ Fermentation
/ Fermentation - drug effects
/ Future predictions
/ Gastrointestinal Microbiome - drug effects
/ Gastrointestinal tract
/ Gene expression
/ Glucosidase
/ Gut microbiome
/ Gut microbiota
/ Hazards
/ Health insurance
/ Hypoglycemic agents
/ Intestinal microflora
/ Life Sciences
/ Life span
/ Longevity
/ Longevity - drug effects
/ Male
/ Males
/ Mice
/ Microbe-host interactions and microbial pathogenicity
/ Microbial activity
/ Microbiology
/ Microbiomes
/ Microbiota
/ Microbiota (Symbiotic organisms)
/ Microorganisms
/ Muribaculaceae
/ Mycology
/ Parasitology
/ Phylogeny
/ Physiology
/ Population
/ Predictive control
/ Propionic acid
/ Proportional Hazards Models
/ Research Article
/ Retirement benefits
/ S24-7
/ Sex
/ Sexes
/ Short-chain fatty acids
/ Standard deviation
/ Starch
/ Survival analysis
/ Taxonomy
/ Virology
/ α-Glucosidase
2019
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice
by
Miller, Richard A
, Strong, Randy
, Schmidt, Thomas M
, Ericsson, Aaron C
, Smith, Byron J
, Harrison, David C
in
Acarbose
/ Acarbose - pharmacology
/ Acetic acid
/ Animals
/ Bacteria
/ Bacteria - classification
/ Bacteria - drug effects
/ Bacteria - isolation & purification
/ Biological Microscopy
/ Biomedical and Life Sciences
/ Case-Control Studies
/ Communities
/ Community composition
/ Composition
/ Dependence
/ Dietary restrictions
/ Digestive system
/ Esters
/ Fatty acids
/ Fatty Acids, Volatile - metabolism
/ Fecal microflora
/ Feces
/ Feces - chemistry
/ Feces - microbiology
/ Female
/ Females
/ Fermentation
/ Fermentation - drug effects
/ Future predictions
/ Gastrointestinal Microbiome - drug effects
/ Gastrointestinal tract
/ Gene expression
/ Glucosidase
/ Gut microbiome
/ Gut microbiota
/ Hazards
/ Health insurance
/ Hypoglycemic agents
/ Intestinal microflora
/ Life Sciences
/ Life span
/ Longevity
/ Longevity - drug effects
/ Male
/ Males
/ Mice
/ Microbe-host interactions and microbial pathogenicity
/ Microbial activity
/ Microbiology
/ Microbiomes
/ Microbiota
/ Microbiota (Symbiotic organisms)
/ Microorganisms
/ Muribaculaceae
/ Mycology
/ Parasitology
/ Phylogeny
/ Physiology
/ Population
/ Predictive control
/ Propionic acid
/ Proportional Hazards Models
/ Research Article
/ Retirement benefits
/ S24-7
/ Sex
/ Sexes
/ Short-chain fatty acids
/ Standard deviation
/ Starch
/ Survival analysis
/ Taxonomy
/ Virology
/ α-Glucosidase
2019
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice
Journal Article
Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice
2019
Request Book From Autostore
and Choose the Collection Method
Overview
Background
Treatment with the
α
-glucosidase inhibitor acarbose increases median lifespan by approximately 20% in male mice and 5% in females. This longevity extension differs from dietary restriction based on a number of features, including the relatively small effects on weight and the sex-specificity of the lifespan effect. By inhibiting host digestion, acarbose increases the flux of starch to the lower digestive system, resulting in changes to the gut microbiota and their fermentation products. Given the documented health benefits of short-chain fatty acids (SCFAs), the dominant products of starch fermentation by gut bacteria, this secondary effect of acarbose could contribute to increased longevity in mice. To explore this hypothesis, we compared the fecal microbiome of mice treated with acarbose to control mice at three independent study sites.
Results
Microbial communities and the concentrations of SCFAs in the feces of mice treated with acarbose were notably different from those of control mice. At all three study sites, the bloom of a single bacterial taxon was the most obvious response to acarbose treatment. The blooming populations were classified to the largely uncultured
Bacteroidales
family
Muribaculaceae
and were the same taxonomic unit at two of the three sites. Propionate concentrations in feces were consistently elevated in treated mice, while the concentrations of acetate and butyrate reflected a dependence on study site. Across all samples,
Muribaculaceae
abundance was strongly correlated with propionate and community composition was an important predictor of SCFA concentrations. Cox proportional hazards regression showed that the fecal concentrations of acetate, butyrate, and propionate were, together, predictive of mouse longevity even while controlling for sex, site, and acarbose.
Conclusion
We observed a correlation between fecal SCFAs and lifespan in mice, suggesting a role of the gut microbiota in the longevity-enhancing properties of acarbose. Treatment modulated the taxonomic composition and fermentation products of the gut microbiome, while the site-dependence of the responses illustrate the challenges facing reproducibility and interpretation in microbiome studies. These results motivate future studies exploring manipulation of the gut microbial community and its fermentation products for increased longevity, testing causal roles of SCFAs in the observed effects of acarbose.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Animals
/ Bacteria
/ Bacteria - isolation & purification
/ Biomedical and Life Sciences
/ Esters
/ Fatty Acids, Volatile - metabolism
/ Feces
/ Female
/ Females
/ Gastrointestinal Microbiome - drug effects
/ Hazards
/ Male
/ Males
/ Mice
/ Microbe-host interactions and microbial pathogenicity
/ Microbiota (Symbiotic organisms)
/ Mycology
/ S24-7
/ Sex
/ Sexes
/ Starch
/ Taxonomy
/ Virology
This website uses cookies to ensure you get the best experience on our website.